NSC 154020 is primarily investigated for its potential applications in cancer research. It has been studied for its ability to inhibit the growth of certain types of cancer cells, making it a candidate for further development in anticancer therapies. Researchers are exploring its mechanism of action, particularly its interaction with cellular pathways involved in tumor progression and apoptosis. Additionally, it is being examined for its potential to enhance the efficacy of existing chemotherapy drugs when used in combination treatments. Its role in targeting specific molecular structures within cancer cells highlights its promise in the development of more targeted and effective cancer treatments.